Skin cream trial to prevent relapses in very dry eczema skin
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is ages 6 months to 15 years
- Your child has eczema (atopic dermatitis) with about 1 flare-up per month in the last 4 months
- At the start visit, the eczema score is in the moderate range (EASI 7.1 to 21)
- On the start visit, there is a current eczema spot that the dermatologist will treat with topical steroid or tacrolimus/pimecrolimus
- Your child must avoid using other skin moisturizers on the study area besides the study cream or its match (placebo)
- Your child cannot have other skin conditions in the treated area like acne or psoriasis, and cannot be allergic to ingredients in the study cream
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
This trial compares two moisturizers for people with eczema (moderate rash) and healthy volunteers. It looks at how well they work and how the skin tolerates them after using a steroid cream.
This trial tests whether a new cream (FilmoCream) plus steroid ointment works better than steroid ointment alone for mild-to-moderate eczema. You must have two separate eczema patches that need steroid treatment.
This trial tests a study drug (PF-08049820) for people with moderate to severe eczema who haven't found a suitable prescription treatment. It aims to see if the drug can improve skin symptoms and itching.
This trial tests an experimental drug called EC-18 (a pill) for people with moderate to severe eczema that hasn't been controlled well with creams. It aims to see if different doses of the drug can safely reduce itching and skin rash.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.